Biogen, Inc. (BIIB)
176.33
+1.51
(+0.86%)
USD |
NASDAQ |
Dec 24, 16:00
Biogen Market Cap: 25.87B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 179.83B |
| Eli Lilly & Co. | 963.92B |
| Merck & Co., Inc. | 264.21B |
| Pfizer Inc. | 142.31B |
| Stoke Therapeutics, Inc. | 1.837B |
Market Cap Related Metrics
| PE Ratio | 16.08 |
| PS Ratio | 2.668 |
| Price to Book Value | 1.421 |
| Price to Free Cash Flow | 11.43 |
| Price | 176.33 |
| Earnings Yield | 6.22% |
| Operating PE Ratio | 10.60 |
| Normalized PE Ratio | 14.26 |